Given the evolving landscape of therapeutic options for RAIR-DTC, it is essential to highlight the importance of timely evaluating patients with advanced thyroid cancer.
Read More
From Clinical Thyroidology® for the Public: Surgery to remove all, or part, of the thyroid…
Latest Impact Factor: Latest Impact Factor: 6.568 The Official Journal of: American Thyroid Association® FREE…
Read and share featured articles from the July issue with free access through August 3,…
From Clinical Thyroidology® for the Public: If surgery is needed in patients with hyperthyroidism, it…
Register today to attend the ATA Annual Meeting on October 19-23, 2022 in Montreal, Canada. Register by July 1, 2022 and save!
Read and share featured articles from the June issue with free access through July 1,…
From Clinical Thyroidology® for the Public: The number of people diagnosed with thyroid cancer every…
Thyroid cancers (TC) are driven by a handful of genetic alterations. Papillary TC primarily harbors mutations involving BRAF, RAS or RET genes.
Read and share featured articles from the May issue with free access through June 12,…
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.